News & Press Releases
News & Press Releases

Morphogenesis, Inc. Signs Agreement to further the Development of Cancer Immunotherapy for Companion Animals
Morphogenesis Inc. and Novartis Animal Health have agreed to collaborate on the development and commercialization of one of Morphogenesis' platform technologies, an investigational immunotherapy treatment for cancers. The objective of this co-development plan will be to produce several canine and feline therapeutic cancer vaccines. Through this agreement, Morphogenesis and Novartis will work closely together to advance the new platform technology to the companion animal market. Morphogenesis is proud to be working with Novartis Animal Health, a company which shares our passion for finding ways to improve the lives of our animal companions. Read the full press release here.


October 30, 2009
SJCH Recieves Patent for Cancer Cure (pg3)
See Newsletter
September, 2009
Morphogenesis Wins PACT Translational Grant
See Story
July 16, 2009
Morphogenesis a Finalist in the 2009 World Technology Network Award for Biotechnology
See Story
June 17, 2009
Lawman Lab Recieves Hyundai Grant 2nd Year in a Row
See Story
December, 2008
Faces of Technology: The Canine Connection (pg7)
See Newsletter
October 3, 2008
SJCH Hematology/Oncology Research Lab Develops Cancer Vaccine
See Newsletter
September 18, 2008
St. Joseph's Children's Hospital Receives Hyundai Grant for Pediatric Cancer Research
Press Release
March 25, 2008
Morphogenesis, Inc. Receives Patent on Immunotherapy for Cancer
Press Release
June 24, 2007
Morphogenesis, Inc. Announces Issuance of Key Stem Cell Patent
Press Release
April 20, 2005
Morphogenesis, Inc. Announces ImmuneFx™ Pre-clinical Results
Press Release